• Inhibrx To Host Webcast Presentation of Topline Results from the Phase 1 Trial of INBRX-101, its Optimized Recombinant Human AAT-Fc Protein for the Treatment of Alpha-1 Antitrypsin Deficiency

    15 days ago - By San Diego Biotechnology

    Event to be webcast live on Monday, May 16, 2022 at 1:30 p.m. PT SAN DIEGO , May 12, 2022 /PRNewswire/ - Inhibrx, Inc. , a biotechnology company with four clinical programs in development...
    Read more ...

     

  • Lineage Cell Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update

    15 days ago - By San Diego Biotechnology

    CARLSBAD, Calif.--- $LCTX LineageCellTherapeutics-Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today reported financial and operating results for the first quarter...
    Read more ...

     

  • Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2022

    15 days ago - By San Diego Biotechnology

    SAN DIEGO, May 12, 2022 /PRNewswire/ - Poseida Therapeutics, Inc. , a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today announced...
    Read more ...

     

  • Regulus Therapeutics Reports First Quarter 2022 Financial Results and Recent Updates

    15 days ago - By San Diego Biotechnology

    FDA Acceptance of Investigational New Drug Application for RGLS8429 for Autosomal Dominant Polycystic Kidney Disease On track to initiate Phase 1 study in second quarter 2022 SAN DIEGO, May 12, 2022 /PRNewswire/ -...
    Read more ...

     

  • Equillium Reports First Quarter 2022 Financial Results and Provides Corporate and Clinical Development Updates

    15 days ago - By San Diego Biotechnology

    LA JOLLA, Calif.--- $EQ-Equillium, Inc. , a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced financial results for the...
    Read more ...